Skip to contentI
ICU Medical Inc
I
ICUIICU Medical Inc Q1 2023 · 10-Q
Revenue$568.65M$568.65M+4.7% vs Q1 2022 Net Income-$9.81M-$9.81MN/M vs Q1 2022 EPS Diluted-$0.41-$0.41N/M vs Q1 2022 Gross Profit$192,041,000+13.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ICU Medical Inc · CIK 883984 · Engraved from SEC EDGAR
Operating Cash Flow$41,245,000N/M Free Cash Flowderived$27,040,000N/M Margins · derivedGross margin33.8%+2.7 pt vs Q1 2022
Operating margin1.7%+9.4 pt vs Q1 2022
Net margin-1.7%+5.3 pt vs Q1 2022
ended Mar 31, 2023 · filed May 9, 2023 · 39 d after period end